The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Processa Pharmaceuticals announced that the company has been assigned the license for CTP-499 upon Promet's exercising of the exclusive option to ...
read more
QurAlis announced the addition of biotech investors MPH, Amgen Ventures, and Alexandria Venture Investments, who have joined to cure Amyotrophic ...
read more
Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in...
read more
On 21 June 2018, the FDA withdrew the draft guidance, "Statistical Approaches to Evaluate Analytical Similarity," issued in September 2017.
read more
Wednesday, September 05, 2018
It is CGPA's understanding that there are many US proposals on the table that would require changes to Canadian law and delay competition from generic...
read more
Thursday, September 13, 2018
Pall Corporation has announced a strategic partnership between its Pall Biotech business unit and Aetos Biologics, a biosimilar cell line development ...
read more
Tuesday, September 25, 2018
The FDA has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to enhance the development of ...
read more
Wednesday, October 10, 2018
Alphamab Oncology announced that its proprietary humanized PD-L1 - CTLA-4 bispecific antibody program, the first of its class, has recently started ...
read more
Liveyon has voluntarily recalled all ReGen Series products due to reported possible adverse reactions.
read more
Tuesday, December 18, 2018
Thermo Fisher Scientific, Roquette Pharma
Roquette and Thermo Fisher Scientific, are announcing a distribution rights agreement for the Roquette portfolio of pharmaceutical ingredients in the ...
read more
Wednesday, December 19, 2018
FDA is announcing the availability of a revised guidance for industry entitled “Clinical Trial Endpoints for the Approval of Cancer Drugs and ...
read more
Wednesday, January 30, 2019
One of our key policy priorities is encouraging the timely development and approval of generics and biosimilars.
read more
Monday, February 04, 2019
VLP Therapeutics announced the FDA has cleared an investigational new drug (IND) application for a clinical trial of the company's VLPM01 malaria ...
read more
Friday, February 15, 2019
Vivacelle Bio announced the FDA has granted it an IND clearance to proceed with its phase IIa clinical trial of the safety and efficacy of VBI-1.
read more
The MDA announced the awarding of 26 new grants totaling more than $7.5 million toward research focused on a variety of rare neuromuscular diseases (...
read more